A retrospective study analysing outcomes of patients in extensive-stage small-cell lung cancer treated with first line immunotherapy Plus chemotherapy
Latest Information Update: 04 Mar 2021
At a glance
- Drugs Atezolizumab (Primary) ; Antineoplastics
- Indications Brain metastases; Small cell lung cancer
- Focus Therapeutic Use
- 04 Mar 2021 New trial record
- 31 Jan 2021 Results presented at the 2020 World Conference on Lung Cancer